Hyperpolarized Xe129
Idiopathic Pulmonary Fibrosis
Clinical trials
3
Developer
University of Virginia
Overview
Hyperpolarized Xe129 is an agent tracked by PF-Atlas in the context of idiopathic pulmonary fibrosis. It appears in 3 tracked IPF clinical trials.
Hyperpolarized Xe129 clinical trials
Explore related
Medical disclaimer. This page summarizes research about Hyperpolarized Xe129 for information only. It is not medical advice. Verify approval status and evidence with the FDA and a pulmonologist.